FIELD: medicine.
SUBSTANCE: invention relates to an injectable pharmaceutical composition containing 15 to 75 mg of dexketoprofen in the form of a salt with tromethamine, 10 to 150 mg of tramadol hydrochloride, ethanol and water for injection. Invention also relates to a process for the preparation of this composition, to a pharmaceutical unit dosage form that contains one, and to its use for the treatment of pain, inflammation and/or fever.
EFFECT: invention provides a stable, long-lasting composition that is effective in relieving pain, from moderate to severe in intensity, and which has fewer side effects.
20 cl, 9 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION OF IBUPROFEN AND TRAMADOL FOR OPHTHALMIC APPLICATION | 2014 |
|
RU2694369C2 |
Pharmaceutical composition based on tramadol for ophthalmic use | 2016 |
|
RU2744570C2 |
PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE CONTAINING A SALT OF DEXKETOPROFEN, AND A PROCESS FOR ITS PREPARATION | 2015 |
|
RU2667465C2 |
DEPOT FORMULATIONS OF HYDROPHOBIC ACTIVE INGREDIENT AND METHODS FOR PREPARATION THEREOF | 2013 |
|
RU2678433C2 |
DEPOT FORMULATIONS OF LOCAL ANESTHETIC AND METHODS FOR PREPARATION THEREOF | 2013 |
|
RU2664700C2 |
STERILE AQUEOUS PHARMACEUTICAL COMPOSITION BASED ON LAZAROID OR ITS PHARMACEUTICALLY ACCEPTABLE SALT FOR PARENTERAL ADMINISTRATION | 1995 |
|
RU2152789C2 |
COMPOSITION CONTAINING SUBSTANCE TRAMADOL AND ACETAMINOPHEN AND A METHOD OF TREATMENT USING THEREOF | 1992 |
|
RU2121346C1 |
(R)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2014 |
|
RU2695607C2 |
CO-CRYSTALS OF TRAMADOL AND COXIBS | 2010 |
|
RU2547830C2 |
SPASMOLYTIC COMPOSITION, METHOD TO OBTAIN SPASMOLYTIC COMPOSITION | 1997 |
|
RU2182016C2 |
Authors
Dates
2018-07-05—Published
2013-04-29—Filed